August 11, 2021European Heart Journal50 citationsOpen Access
View Full PaperNovel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial
Structured PICO
Does a biomarker-driven prognostic model combining NT-proBNP and hs-cTnT with clinical variables predict morbidity and mortality in patients with HFrEF?
P
Population
Patients with HFrEF (chronic heart failure with reduced ejection fraction)
I
Intervention
Biomarker-driven prognostic models combining NT-proBNP and hs-cTnT with readily available clinical variables
O
Outcome
Morbidity and mortalityhard clinical
A predictive tool kit combining NT-proBNP, hs-cTnT, and basic clinical variables can be easily implemented for routine prognostic assessment in HFrEF.
Abstract
The combination of NT-proBNP and hs-cTnT with a small number of readily available clinical variables provides prognostic assessment for patients with HFrEF. This predictive tool kit can be easily implemented for routine clinical use.